Summary & Overview
HCPCS C9725: Endorectal Intracavitary Applicator Placement for High-Intensity Brachytherapy
HCPCS Level II code C9725 denotes the placement of an endorectal intracavitary applicator for high intensity brachytherapy, a procedure used to position a device that delivers concentrated radiation to rectal or nearby pelvic tumors. Nationally, this code matters because it identifies a specialized radiation oncology service with implications for facility utilization, coding consistency, and payment policy across commercial insurers and Medicare. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn the clinical context of the procedure, typical sites of service (ambulatory surgical centers and hospital outpatient departments), common billing considerations, and the landscape of payer coverage. The summary includes benchmark concepts and policy-relevant points such as how payers classify and reimburse intracavitary brachytherapy placement, which impacts facility and professional billing. Where specific data was not provided in the input, the publication will note that those elements are not available and focus on available descriptive, clinical, and payer coverage information to inform coding accuracy and revenue-cycle considerations.
Billing Code Overview
HCPCS Level II code C9725 describes the placement of an endorectal intracavitary applicator for high intensity brachytherapy. This service involves the insertion and positioning of a specialized intracavitary applicator into the rectum to deliver high-dose-rate brachytherapy to pelvic or rectal neoplasms.
-
Service type: High-intensity brachytherapy applicator placement
-
Typical site of service: Ambulatory surgical center or hospital outpatient department
Clinical & Coding Specifications
Clinical Context
A typical patient is a 65-year-old male with localized rectal adenocarcinoma or recurrent rectal cancer who is scheduled for high-dose-rate (HDR) endorectal intracavitary brachytherapy. The clinical workflow begins with multidisciplinary evaluation by radiation oncology, colorectal surgery, and medical oncology. Preprocedural planning includes history and physical, review of prior imaging (pelvic MRI or CT), tumor mapping, and informed consent. On the day of service the patient is placed in a lithotomy or left lateral decubitus position in an outpatient or ambulatory radiation treatment suite or a hospital-based radiation oncology department. Under conscious sedation or monitored anesthesia care, the radiation oncologist or qualified brachytherapist dilates the rectum as needed and places an endorectal intracavitary applicator into the rectal lumen, positioning the device adjacent to the tumor. After applicator placement, treatment planning imaging (fluoroscopy, CT simulation, or cone-beam CT) is performed to confirm applicator position and to create a brachytherapy treatment plan. The HDR afterloader delivers prescribed fractions; applicator removal follows once treatment is complete. Postprocedure monitoring for immediate complications (bleeding, pain, vasovagal reaction) occurs prior to discharge. Documentation should include indication, informed consent, sedation/ anesthesia level, applicator type and size, method of placement, imaging used for planning, dwell positions and dose per fraction in the plan, and any complications or concurrent procedures.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |